Testing how to use genetic medicine results in routine care
Part of Blood & lymphatic, Digestive system, Heart & circulation, Immune system & allergy, Infections clinical trials.
This study looks at how to put genetic testing results (pharmacogenomics) into regular doctor care. It aims to see whether using the results helps doctors choose safer, better-matched medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and receive regular outpatient care at the University of Chicago Medical Center
- You are expected to live at least 3 more years
- You take 1 to 6 prescription medicines now, or you are 65+, or you expect to need prescription medicines within 5 years
- You may be especially likely to be invited if you have conditions like long-term blood thinner needs, inflammatory bowel disease, autoimmune/inflammation conditions, hepatitis C, or non-metastatic cancer, or specialized heart care
- You should not have a serious condition expected to cause death within 3 years
- You should not be getting ready for a liver or kidney transplant
- You must be able to understand and give consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses personalized information to help understand how your current medicines interact with each other and with your genes. It may help your care team choose safer, more effective medication plans for you.
This study looks at whether using a person’s genetic information helps doctors make better decisions during planned surgery. It may help tailor care, but you would only join if you can consent and don’t have certain serious conditions.
This trial tests whether a “point-of-care” computer tool can help clinicians use a person’s genetic information to choose safer, better medication decisions. It focuses on helping reduce treatment differences for African American patients.
This study looks at whether knowing your genetic makeup can help doctors choose the safest and most effective pain medicine for you before you start taking opioids. If you are being treated for cancer and may need opioid pain medication soon, this trial might be a fit.
This trial checks if genetic testing can help doctors pick safer drugs for you when you are in the hospital or visiting a clinic. If you qualify, you will give a cheek swab and be followed for about 12 weeks.
This study collects blood, urine, and cheek swabs, along with health information, to see how your genes affect your response to medications. You may be eligible if you take many medications or are on blood pressure or depression medication.
Hear when a new Heart Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.